In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis

As a consequence of emerging numbers of vulvovaginitis cases caused by azole-resistant and biofilm-forming Candida species, fast and efficient treatment of this infection has become challenging. The problem is further exacerbated by the severe side effects of azoles as long-term-use medications in t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Kovács, Renátó, Holzknecht, Jeanett, Hargitai, Zoltán, Papp, Csaba, Farkas, Attila, Borics, Attila, Tóth, Lilána, Váradi, Györgyi, Tóth, Gábor K., Kovács, Ilona, Dubrac, Sandrine, Majoros, László, Marx, Florentine, Galgóczy, László
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2019
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355578/
https://ncbi.nlm.nih.gov/pubmed/30478163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01777-18
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires